1. Home
  2. AKRO vs HTLF Comparison

AKRO vs HTLF Comparison

Compare AKRO & HTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • HTLF
  • Stock Information
  • Founded
  • AKRO 2017
  • HTLF 1981
  • Country
  • AKRO United States
  • HTLF United States
  • Employees
  • AKRO N/A
  • HTLF N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • HTLF Major Banks
  • Sector
  • AKRO Health Care
  • HTLF Finance
  • Exchange
  • AKRO Nasdaq
  • HTLF Nasdaq
  • Market Cap
  • AKRO 2.2B
  • HTLF 2.5B
  • IPO Year
  • AKRO 2019
  • HTLF N/A
  • Fundamental
  • Price
  • AKRO $29.53
  • HTLF $65.21
  • Analyst Decision
  • AKRO Strong Buy
  • HTLF Buy
  • Analyst Count
  • AKRO 8
  • HTLF 5
  • Target Price
  • AKRO $46.83
  • HTLF $45.60
  • AVG Volume (30 Days)
  • AKRO 535.2K
  • HTLF 175.8K
  • Earning Date
  • AKRO 11-08-2024
  • HTLF 01-27-2025
  • Dividend Yield
  • AKRO N/A
  • HTLF 1.79%
  • EPS Growth
  • AKRO N/A
  • HTLF N/A
  • EPS
  • AKRO N/A
  • HTLF 1.80
  • Revenue
  • AKRO N/A
  • HTLF $571,472,000.00
  • Revenue This Year
  • AKRO N/A
  • HTLF N/A
  • Revenue Next Year
  • AKRO N/A
  • HTLF N/A
  • P/E Ratio
  • AKRO N/A
  • HTLF $36.21
  • Revenue Growth
  • AKRO N/A
  • HTLF N/A
  • 52 Week Low
  • AKRO $15.32
  • HTLF $32.03
  • 52 Week High
  • AKRO $37.00
  • HTLF $70.27
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 46.87
  • HTLF 48.20
  • Support Level
  • AKRO $28.45
  • HTLF $64.64
  • Resistance Level
  • AKRO $31.41
  • HTLF $66.97
  • Average True Range (ATR)
  • AKRO 1.29
  • HTLF 1.57
  • MACD
  • AKRO -0.15
  • HTLF -0.56
  • Stochastic Oscillator
  • AKRO 37.64
  • HTLF 16.99

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

About HTLF Heartland Financial USA Inc.

Heartland Financial USA Inc is a multi-bank holding company that offers a wide range of commercial, small business, and consumer banking services to businesses, including public sector and non-profit entities and individuals. It also provides traditional and non-traditional service channels including online banking, mobile and remote banking, and telephone banking. The company's business lines are Commercial Banking, Agricultural Loans, Small Business Banking, Residential Real Estate Mortgage Lending, Consumer Banking, and Wealth Management and Retirement Plan Services.

Share on Social Networks: